Cargando…

Targeting lymphatics in inflammatory bowel disease

Detalles Bibliográficos
Autores principales:	D'Aiessio, Silvia, Tacconi, Carlotta, Danese, Silvio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741425/ https://www.ncbi.nlm.nih.gov/pubmed/26452136

Ejemplares similares

Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Landscape of new drugs and targets in inflammatory bowel disease
por: Vieujean, Sophie, et al.
Publicado: (2022)

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
por: Spadaccini, Marco, et al.
Publicado: (2017)

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?
por: Furfaro, Federica, et al.
Publicado: (2021)

Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
por: Ungaro, Federica, et al.
Publicado: (2017)

The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
por: Garlatti, Valentina, et al.
Publicado: (2021)

Can we change the natural course of inflammatory bowel disease?
por: Le Berre, Catherine, et al.
Publicado: (2023)

Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge
por: Wils, Pauline, et al.
Publicado: (2022)

Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021)

The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease
por: Nikolakis, Dimitrios, et al.
Publicado: (2022)

The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
por: Solitano, Virginia, et al.
Publicado: (2021)

Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease
por: Honap, Sailish, et al.
Publicado: (2023)

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
por: Genua, Marco, et al.
Publicado: (2014)

Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic
por: Kotze, Paulo Gustavo, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Epigenetic regulation of the lineage specificity of primary human dermal lymphatic and blood vascular endothelial cells
por: Tacconi, Carlotta, et al.
Publicado: (2020)

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future
por: Solitano, Virginia, et al.
Publicado: (2022)

Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease
por: Houshyar, Yashar, et al.
Publicado: (2021)

Systematic review—pancreatic involvement in inflammatory bowel disease
por: Massironi, Sara, et al.
Publicado: (2022)

Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn’s and Colitis Organization
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
por: Papa, Alfredo, et al.
Publicado: (2020)

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
por: D'Amico, Ferdinando, et al.
Publicado: (2020)

Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
por: Filidou, Eirini, et al.
Publicado: (2023)

Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era
por: Cuny, Alix, et al.
Publicado: (2022)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art
por: Vespa, Edoardo, et al.
Publicado: (2022)

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
por: Dotan, Iris, et al.
Publicado: (2019)

Viral infections in inflammatory bowel disease: Tips and tricks for correct management
por: Craviotto, Vincenzo, et al.
Publicado: (2021)

Ultrasound Elastography in Inflammatory Bowel Diseases: A Systematic Review of Accuracy Compared with Histopathological Assessment
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pddh3eg19cllqgshnl3b84hb1m